FHLC vs PBE: holdings overlap, shared companies and scores
As of October 9, 2026, FHLC and PBE overlap 13.2% by weight. Fidelity MSCI Health Care Index ETF (FHLC): U.S. healthcare companies Invesco Biotechnology & Genome ETF (PBE): US biotech and genome stocks
Updated October 9, 2026
Where FHLC and PBE trade against their own history
FHLC trades at 30.7 times earnings, against its own median of 25.3, and is more expensive than 91% of its own last 9 years.
PBE trades at 25.3 times earnings, against its own median of 22.1, and is more expensive than 67% of its own last 9 years.
What moved FHLC and PBE this week
FHLC rose 2.3% in the week to October 9, 2026. The holdings that moved it most were Eli Lilly (+3.2%), Abbvie (+5.2%) and Johnson & Johnson (+2.1%); Bristol-Myers Squibb (−3.3%) pushed the other way.
PBE rose 1.9% in the week to October 9, 2026. The holdings that moved it most were Novavax (+21.9%), Moderna (+18.4%) and Gilead Sciences (+4.4%); Natera (−2.3%) pushed the other way.
What do FHLC and PBE each hold?
What's inside FHLC: AI 1%.
51% of FHLC is its ten largest holdings.
48% of PBE is its ten largest holdings.
How much do FHLC and PBE overlap? 13.2% by weight
As of October 9, 2026, FHLC and PBE overlap 13.2% by weight.
13% of FHLC is already inside PBE.
95% of PBE is already inside FHLC.
FHLC holds 329 companies and PBE holds 30; 28 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score FHLC and PBE? 5.3 and 4.8 out of 10
As of October 9, 2026, ETF Copilot scores FHLC 5.3 out of 10 and PBE 4.8 out of 10.
They differ most on Risk: FHLC 8.2 and PBE 3.4.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | FHLC | PBE |
|---|---|---|
| Growth | 6.4 | 9.7 |
| Value | 2.1 | 2.5 |
| Risk | 8.2 | 3.4 |
| Quality | 5.4 | 1.8 |
| Return | 4.2 | 4.3 |
FHLC is the cheaper of the two at 0.08% a year
As of October 9, 2026, FHLC charges 0.08% a year, yields 1.23% and holds $3.6B in assets across 329 positions.
As of October 9, 2026, PBE charges 0.59% a year, yields 1.36% and holds $410M in assets across 30 positions.
| Measure | FHLC | PBE |
|---|---|---|
| Expense ratio | 0.08% | 0.59% |
| Dividend yield | 1.23% | 1.36% |
| Assets under management | $3.6B | $410M |
| Holdings | 329 | 30 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Compare with similar funds
Cite this
ETF Copilot, “FHLC vs PBE holdings overlap and scores”, as of October 9, 2026.
https://etf-copilot.com/compare/fhlc-vs-pbe
ETF Copilot Pro unlocks FHLC vs PBE prices and holdings.
Try Pro free →